Ranibizumab (Lucentis®) intravítreo en el tratamiento de membrana neovascular coroidea secundaria a coroidopatía punctata interna
- A. Valverde Megías
- P. Arriola Villalobos
- J. Reche Frutos
- J. Donate López
- C. Calvo González
- J. García Feijoo
ISSN: 0365-6691
Any de publicació: 2010
Volum: 85
Número: 4
Pàgines: 149-152
Tipus: Article
Altres publicacions en: Archivos de la Sociedad Española de Oftalmologia
Resum
Clinic case: A 25 year old patient with high myopia diagnosed of metachronic choroidal neovascularisation in both eyes secondary to punctate inner choroidopathy leading to visual impairment and metamorphopsia. First eye was treated with four injections of ranibizumab after photodynamic therapy and the second eye only with charge dose of ranibizumab, reaching inactivity with good final visual acuity in both eyes. Discussion: Ranibizumab is useful in the treatment of this illness. Prospective studies are needed to investigate the usefulness of a combination with adjuvant therapies such as photodynamic therapy.
Referències bibliogràfiques
- Gerstenblith, AT, Thorne, JE, Sobrin, L, Do, DV, Shah, SM, Foster, CS. (2007). Punctate Inner Choroidopathy: A Survey Analysis of 77 Persons. Ophthalmology. 114. 1201
- Machida, S, Fujiwara, T, Murai, K, Kubo, M, Kurosaka, D. (2008). Idiopathic Choroidal Neovascularization as an early manifestation of inflammatory chorioretinal diseases. Retina. 28. 703
- Rogers, AH, Duker, JS, Nichols, N, Baker, BJ. (2003). Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology. 110. 1315
- Adán, A, Mateo, C, Navarro, R, Bitrian, E, Casaroli-Marano, RP. (2007). Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularisation. Retina. 27. 1180
- Fine, HF, Zhitomirsky, I, Freund, KB, Barile, GR, Shirkey, BL, Samson, CM. (2009). Bevacizumab (Avastin) and ranibizumab (Lucentis) for choroidal neovascularization in multifocal choroiditis. Retina. 29. 8-12